One Trip, One Month of Change: What Psilocybin Does to Your Brain

What the researchers did

Scientists at UC San Francisco (UCSF) and Imperial College London recruited healthy volunteers who had never taken a psychedelic before. Starting from zero removes any previous experience from the equation, which makes the results cleaner and more reliable.

Each person went through two sessions. First, they received 1 mg of psilocybin — low enough to act as a placebo. One month later, they took a full 25 mg dose, which is enough for a strong psychedelic experience. The team used two types of brain scanning:

By combining these two tools, they could directly link what happens during the trip to the psilocybin brain changes that appear long after it ends.

Three psilocybin brain changes the study found

1. Brain entropy surges within 60 minutes

Within an hour of taking the 25 mg dose, EEG readings showed a sharp rise in brain entropy — a measure of how unpredictable and varied the brain's electrical signals are. Under normal conditions, the brain runs on repeating patterns. High entropy breaks those patterns. The brain starts processing a wider and richer range of information at once, which scientists connect to insight, creativity, and flexible thinking.

2. The strength of the trip predicts well-being one month later

Here is what made this study stand out: the amount of entropy during the experience directly predicted well-being outcomes four weeks later. People with the strongest entropy increase were most likely to:

"Psilocybin seems to loosen up stereotyped patterns of brain activity and give people the ability to revise entrenched patterns of thought," said Taylor Lyons, PhD, first author and research associate at Imperial College London.

3. White matter tracts become physically denser

One month after the high-dose session, DTI scans showed that participants' white matter tracts — the long fibre bundles connecting different brain regions — had become denser and more structurally intact. The researchers saw the clearest psilocybin brain changes in the prefrontal-subcortical pathways: the connections between the front of the brain (decision-making, emotional regulation) and deeper structures (memory, mood). These pathways normally weaken as we age. Here, they grew stronger.

Why the trip itself matters — not just the molecule

A key question in psilocybin science right now is: does the trip itself cause the benefit, or could a non-hallucinogenic version of psilocybin work just as well? We covered that debate in our earlier post on psilocybin without hallucinations. This new study comes down firmly on one side: the experience matters.

The entropy boost during the trip was the key predictor of every positive outcome — including the anatomical psilocybin brain changes seen a month later. The researchers conclude that the feeling of psychological insight during the session is not a side effect. It appears to be the mechanism.

"Our data shows that experiences of psychological insight relate to an entropic quality of brain activity, and that both are involved in causing subsequent improvements in mental health," said Robin Carhart-Harris, head of the Neuroscape Psychedelics Division at UCSF and one of the study's senior authors. "It suggests that the trip — and its correlates in the brain — is a key component of how psychedelic therapy works."

This connects to what the largest psychedelic brain study ever found earlier this year: all classic psychedelics disrupt and reorganise brain network activity in a shared way. The new UCSF–Imperial study now shows that this disruption leaves a physical mark lasting at least one month.

Psilocybin brain changes and neuroplasticity: the bigger picture

We previously covered how psilocybin may stimulate the growth of new brain cells — boosting BDNF and neurogenesis in the hippocampus at the cellular level. The new study adds a layer above that: changes at the tract level, the long-range motorways between brain regions. Together, these findings suggest psilocybin promotes plasticity at multiple scales — from individual synapses all the way up to the broad architecture of how the brain is wired.

This multi-level neuroplasticity may explain why the improvements in mood, cognition, and even movement seen in Parkinson's patients after a psilocybin session are so broad. Better-connected prefrontal-subcortical tracts could help explain why depression, rigid thinking, and emotional dysregulation all respond to psilocybin therapy.

What this means if you are curious about psilocybin

The participants who experienced the most entropy — and therefore the most benefit — were not necessarily those who resisted the experience. They were the ones who were fully present, who allowed the disruption of their normal patterns. That means preparation, intention, and a safe environment are not luxuries. They may be the conditions that let the brain do its deepest work.

If you are exploring tripping alone or for the first time, read our full safety guide before you start. And if you want to understand whether magic mushrooms are actually dangerous, our science-based risk guide covers everything you need to know.

What comes next for psilocybin brain research

One practical implication: EEG entropy during a session could become a real-time biomarker — a way to know, while the session is still happening, whether the conditions for lasting psilocybin brain changes are being met. That would be a major step toward personalised psilocybin therapy.

The research momentum is building fast. Earlier this year, the Trump administration signed an executive order to fast-track psilocybin and ibogaine research in the US. And the Czech Republic became the first EU country where psychiatrists can legally prescribe psilocybin therapy. This new Nature Communications study gives both clinical and policy developments a powerful scientific foundation.

The full paper — Human brain changes after first psilocybin use — was published on 5 May 2026 in Nature Communications by Taylor Lyons, Robin Carhart-Harris and colleagues at UCSF and Imperial College London. You can read the original research on Nature.com and the UCSF press release on ucsf.edu.